Benefits and Programme Portfolio Review
Public-sector portfolios contain programmes with different objectives, beneficiaries, time horizons and evidence. Leaders still need to allocate one constrained budget across them. Converting every outcome into one score can make the ranking look objective while hiding uncertainty, distribution and political judgement.
Marketways reconstructs the intended benefit, tests the evidence and models the dependencies and choices available for each programme. The portfolio review shows which programmes should expand, change, combine, pause or stop and preserves the reason behind every recommendation.
Start with the public outcome
A programme can spend its budget and complete its activities without improving the intended condition. Delivery evidence matters, but it does not by itself establish public value.
Marketways constructs the chain from resources and activities through reach and intermediate change to the intended outcome. We state the assumptions that connect each stage and the evidence available to test them.
The chain separates an implementation failure from an implausible programme design. Management can then decide whether better delivery could recover the benefit or whether the intervention itself requires redesign.
Compare evidence as well as expected benefit
Two programmes may promise similar benefits while relying on very different evidence. A tested intervention with stable delivery should not receive the same confidence as an untested forecast built on several unsupported assumptions.
Marketways assesses evidence relevance, quality and maturity at each point in the benefit chain. We distinguish observed outcomes, credible estimates, early indicators and management assumptions.
The portfolio view therefore shows expected benefit and confidence separately. A large uncertain claim cannot dominate merely because its central estimate is high.
Preserve outcomes that cannot be reduced to money
Health, safety, access, economic and environmental outcomes cannot always be converted into one defensible monetary unit. Forcing conversion can obscure ethical priorities and who receives the benefit.
Marketways uses monetised evidence where it is credible and retains material unmonetised outcomes, distributional effects and obligations. A structured decision model can compare programmes through explicit criteria without pretending that every criterion is equivalent.
Weights and trade-offs remain visible to leaders. The analysis supports judgement; it does not hide policy choices inside a formula.
Model dependencies across the portfolio
A programme can have a strong standalone case and still fail because it depends on another agency, shared infrastructure, skilled staff or a preceding investment. Funding every strong individual case can therefore produce a weak portfolio.
Marketways maps enabling, competing and shared dependencies. We test whether programmes require a sequence, can share capability or create demand that another service cannot absorb.
This analysis can justify funding an enabling programme first, combining related investments or delaying a dependent initiative. It also prevents two programmes from claiming the same benefit independently.
Use staged commitment when evidence can improve
Uncertainty does not always require full expansion or cancellation. Management may pilot a programme, release funding in stages or preserve the option to expand when evidence improves.
Marketways identifies the uncertainty that changes the decision and the evidence capable of resolving it. We compare the value of learning with the cost of delay and the risk of an irreversible commitment.
Further research has little value when it would not change the choice. A targeted pilot is useful when one uncertain assumption determines whether expansion creates public value.
Test the portfolio against constrained resources
Projects compete for more than budget. They can require the same specialists, procurement capacity, data, leadership attention or change tolerance.
Marketways compares portfolio combinations under these constraints. We examine what management must defer and whether the remaining mix still covers mandatory and strategic outcomes.
The result is a feasible programme set rather than a ranked list that assumes every attractive proposal can proceed simultaneously.
Define review triggers before approval
An approval should state the outcome expected, evidence required, dependency assumed and condition that reopens the decision. Without these triggers, continued funding can become the default even after the original case changes.
Marketways defines milestones for learning and benefit realisation. A programme may expand, change, combine, pause or stop when the evidence crosses an agreed threshold.
The review record preserves management judgement and uncertainty at the time of decision. Later reviewers can distinguish a failed assumption from poor execution or an external change.
Use AI to maintain evidence, not select public priorities
An Agentic AI workflow can retrieve programme reports, track assumptions and alert managers when evidence or dependencies change. It can prepare consistent comparison material across a large portfolio.
The workflow must not decide the relative importance of public outcomes or allocate funding autonomously. Leaders approve the criteria, trade-offs and distributional priorities.
Every recommendation should preserve its sources, model assumptions and human judgement. Automation should improve the timeliness of review without obscuring accountability.
A digital-service dependency changes the choice
Suppose a digital-service programme depends on identity infrastructure, staff capability and data from another agency. Its standalone forecast shows substantial benefit.
Dependency analysis may show that the benefit cannot arrive on schedule because the shared identity service is not ready. A staged portfolio can fund the enabling capability first and release the dependent investment only after a readiness test.
Management preserves the strategic objective without committing the full budget to a sequence that cannot yet work. The portfolio decision changes because dependency and option value are visible.
How Marketways supports portfolio decisions
Marketways defines the decision criteria, reconstructs each programme's benefit chain and assesses the strength of the available evidence. We model dependencies, uncertainty, constraints and staged options before comparing the portfolio.
The engagement can combine Decision Assurance, Business Feasibility Study and Decision Analysis and Prioritisation. The result is a traceable allocation decision rather than a league table of unlike programmes.